Also known as آسٹیوپوروسس مینجمنٹ
Internal Medicine Specialist
M.B.B.S., F.C.P.S. (Medicine)
Internal Medicine Specialist
MBBS, Diploma in Internal Medicine, Certified in Diabetes, Certified in Endocrinology
Internal Medicine Specialist
MBBS, Diploma in Internal Medicine, Certified in Diabetes, Certified in Endocrinology
Endocrinologist
MBBS, FCPS ( Medicine ), FCPS ( Endocrinology )
Internal Medicine Specialist
M.B.B.S., F.C.P.S.
Internal Medicine Specialist
MBBS, FCPS (Medicine), MRCP UK ( Internal Medicine), SCE UK (Endocrinology and Diabetes)
Internal Medicine Specialist
MBBS, FCPS (Medicine), MRCP UK ( Internal Medicine), SCE UK (Endocrinology and Diabetes)
Family Physician
MBBS (pak) , FCPS (pak) , MRCGP (UK), MRCS (UK), CCT (UK) , PG CERT, Diabetes (UK), MCFPC (Canada)
Family Physician
MBBS (pak) , FCPS (pak) , MRCGP (UK), MRCS (UK), CCT (UK) , PG CERT, Diabetes (UK), MCFPC (Canada)
Internal Medicine Specialist
M.B.B.S, F.C.P.S. (Medicine), M.C.P.S
Internal Medicine Specialist
M.B.B.S, F.C.P.S. (Medicine), M.C.P.S
Gastroenterologist
M.B.B.S, MACG, M.D (Gastroenterology), MRCP-1
Internal Medicine Specialist
MBBS, FCPS
Internal Medicine Specialist
MBBS, MD Internal Medicine
Bisphosphonates are used as first-line pharmacologictreatment for osteoporosis. In patients who cannot tolerate or whose symptoms do not improve with bisphosphonate therapy, teriparatide (Forteo) and denosumab (Prolia) are effective alternative medications to prevent osteoporotic fractures